1. Home
  2. SNPX vs GPATU Comparison

SNPX vs GPATU Comparison

Compare SNPX & GPATU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNPX
  • GPATU
  • Stock Information
  • Founded
  • SNPX 2012
  • GPATU N/A
  • Country
  • SNPX United States
  • GPATU
  • Employees
  • SNPX 5
  • GPATU N/A
  • Industry
  • SNPX Medicinal Chemicals and Botanical Products
  • GPATU
  • Sector
  • SNPX Health Care
  • GPATU
  • Exchange
  • SNPX Nasdaq
  • GPATU NYSE
  • Market Cap
  • SNPX 3.3M
  • GPATU N/A
  • IPO Year
  • SNPX N/A
  • GPATU N/A
  • Fundamental
  • Price
  • SNPX $2.35
  • GPATU $10.42
  • Analyst Decision
  • SNPX Strong Buy
  • GPATU
  • Analyst Count
  • SNPX 1
  • GPATU 0
  • Target Price
  • SNPX $14.00
  • GPATU N/A
  • AVG Volume (30 Days)
  • SNPX 7.8K
  • GPATU N/A
  • Earning Date
  • SNPX 05-14-2025
  • GPATU N/A
  • Dividend Yield
  • SNPX N/A
  • GPATU N/A
  • EPS Growth
  • SNPX N/A
  • GPATU N/A
  • EPS
  • SNPX N/A
  • GPATU N/A
  • Revenue
  • SNPX N/A
  • GPATU N/A
  • Revenue This Year
  • SNPX N/A
  • GPATU N/A
  • Revenue Next Year
  • SNPX N/A
  • GPATU N/A
  • P/E Ratio
  • SNPX N/A
  • GPATU N/A
  • Revenue Growth
  • SNPX N/A
  • GPATU N/A
  • 52 Week Low
  • SNPX $2.15
  • GPATU N/A
  • 52 Week High
  • SNPX $6.22
  • GPATU N/A
  • Technical
  • Relative Strength Index (RSI)
  • SNPX 35.26
  • GPATU N/A
  • Support Level
  • SNPX $2.42
  • GPATU N/A
  • Resistance Level
  • SNPX $2.78
  • GPATU N/A
  • Average True Range (ATR)
  • SNPX 0.16
  • GPATU 0.00
  • MACD
  • SNPX -0.02
  • GPATU 0.00
  • Stochastic Oscillator
  • SNPX 31.02
  • GPATU 0.00

About SNPX Synaptogenix Inc.

Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.

About GPATU GP-ACT III ACQUISITION CORP

GP-Act III Acquisition Corp is a blank check company.

Share on Social Networks: